Secosteroidal hydrazides: Promising scaffolds for anti-breast cancer agents

J Steroid Biochem Mol Biol. 2021 Nov:214:106000. doi: 10.1016/j.jsbmb.2021.106000. Epub 2021 Sep 20.

Abstract

A convenient and selective approach to 13,17-secoestra-1,3,5(10)-trien-17-oic acid hydrazides and their N'-(het)arylmethylene derivatives was disclosed and these novel types of secosteroids were screened for cytotoxicity against hormone-dependent human breast cancer cell line MCF-7. A number of 13,17-secoestra-1,3,5(10)-trien-17-oic acid [N'-(het)arylmethylene]hydrazides show significant cytotoxic effect comparable or superior to that for reference drug cisplatin. Compound 3l exhibits the highest activity with the IC50 value of about 2 μM and is 2.8 times more active than cisplatin. Hit 13,17-secoestra-1,3,5(10)-trien-17-oic acid [N'-(het)arylmethylene]hydrazides 3d, 3l and 3q are characterized by high cytotoxicity and good selectivity towards MCF-7 breast cancer cells. The synthesized secosteroids may be considered as new promising antitumor agents.

Keywords: Azomethines; Breast cancer; Cytotoxicity; D-Secosteroids; Hydrazides; Steroidal lactones.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Antineoplastic Agents / pharmacology*
  • Breast / drug effects
  • Breast Neoplasms / drug therapy*
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Chemistry, Pharmaceutical / methods
  • Drug Design
  • Drug Screening Assays, Antitumor
  • Female
  • Humans
  • Hydrazines / chemistry*
  • Inhibitory Concentration 50
  • Lactones / chemistry
  • MCF-7 Cells
  • Magnetic Resonance Spectroscopy
  • Molecular Structure
  • Steroids / chemistry
  • Structure-Activity Relationship

Substances

  • Anti-Bacterial Agents
  • Antineoplastic Agents
  • Hydrazines
  • Lactones
  • Steroids